Evidence map›Paper›PMID 29427161›Full record

ReviewTransgenic research2018

Safety of Pseudomonas chlororaphis as a gene source for genetically modified crops.

Jennifer A Anderson, Jamie Staley, Mary Challender, Jamie Heuton

Abstract readReview
In one paragraph

Review in Transgenic research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Microorganisms · 2025
    Article
  4. Article
  5. New Insights intoAntibiotics (Basel, Switzerland) · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Isolation and Characterization ofPlants (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Article
  13. LeveragingFrontiers in microbiology · 2021
    Review
  14. Article
  15. Article
  16. Bacteria from the Midgut of Common Cockchafer (International journal of molecular sciences · 2020
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jennifer A AndersonDuPont Pioneer, 8325 NW 62nd Avenue, Johnston, IA, 50131, USA. jennifer.anderson@pioneer.com.
Jamie StaleyDuPont Pioneer, 8325 NW 62nd Avenue, Johnston, IA, 50131, USA.
Mary ChallenderDuPont Pioneer, 8325 NW 62nd Avenue, Johnston, IA, 50131, USA.
Jamie HeutonDuPont Pioneer, 8325 NW 62nd Avenue, Johnston, IA, 50131, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetically modified crops undergo extensive evaluation to characterize their food, feed and environmental safety prior to commercial introduction, using a well-established, science-based assessment framework. One component of the safety assessment includes an evaluation of each introduced trait, including its source organism, for potential adverse pathogenic, toxic and allergenic effects. Several Pseudomonas species have a history of safe use in agriculture and certain species represent a source of genes with insecticidal properties. The ipd072Aa gene from P. chlororaphis encodes the IPD072Aa protein, which confers protection against certain coleopteran pests when expressed in maize plants. P. chlororaphis is ubiquitous in the environment, lacks known toxic or allergenic properties, and has a history of safe use in agriculture and in food and feed crops. This information supports, in part, the safety assessment of potential traits, such as IPD072Aa, that are derived from this source organism.

Indexed as

Plants, Genetically ModifiedBacterial ProteinsBiological Control AgentsCrops, AgriculturalInsecticidesPhylogenyPseudomonas chlororaphisZea maysBacterial ProteinsBiological Control AgentsInsecticidesAgricultural biotechnologyGenetically modified cropsInsect protectionPseudomonas chlororaphisSafety assessment

Identifiers

PMID29427161
PMCPMC5847145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.